Developing the first effective treatment for hypothyroidism


  • A disease affecting more than 750M – with 80% patients dissatisfied.
  • Current treatments are unable to follow healthy thyroid gland release cycles.
  • ProLevi develops a modified release thyroid hormone formulation mimicking the circadian rhythm.

T3 and TSH levels follow the circadian clock

Problem with current treatments

  • Failure to mimic T3 natural release cycles
  • T3 today is immediate release with short half life
  • Poor patient compliance (T3 dosing thrice a day)
  • Overdosing and long-term side-effects

Intellectual Property

Contact us

c/o Ekonomihuset Moberg AB
Geijersgatan 4 B 216 18 Limhamn